Skip to main content
SpringerLink
Log in

Acute Coronary Syndromes

  • Chapter
Cardiology in Family Practice

Part of the book series: Current Clinical Practice ((CCP))

  • 434 Accesses

Abstract

Acute coronary syndromes (ACS) describe the spectrum of disease in patients who present with any constellation of clinical symptoms that are compatible with acute myocardial ischemia. ACS are a family of disorders that share similar pathogenic mechanisms and represent different points along a common continuum. These syndromes are caused by recent thrombus formation on pre-existing coronary artery plaque leading to impaired myocardial oxygen supply. In this sense, they differ from stable angina, which is usually precipitated by increased myocardial oxygen demand (e.g., exertion, fever, tachycardia) with background coronary artery narrowing (limitation of oxygen supply). (See Fig. 1.)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ambrose JA, Martinez EE. A new paradigm for plaque stabilization. Circulation 105:2000–2004, 2002.

    Article  PubMed  Google Scholar 

  2. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349:733–742, 2003.

    Article  PubMed  Google Scholar 

  3. Antman EM, Cohen M, Radley D, et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation 100:1602–1608, 1999.

    PubMed  CAS  Google Scholar 

  4. Assessment of the Safety and Efficacy of a New Thrombolytic Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 354:716–722, 1999.

    Article  Google Scholar 

  5. Aversano T, Aversano LT, Passamani E, et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA 287:1943–1951, 2002.

    Article  PubMed  Google Scholar 

  6. Bates ER, Stomel RJ, Hochman JS, Ohman EM. The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock. Int J Cardiol 65Suppl 1:S37–42, 1998.

    Article  PubMed  Google Scholar 

  7. Becker RC. Hemodynamic, mechanical, and metabolic determinants of thrombolytic efficacy: a theoretic framework for assessing the limitations of thrombolysis in patients with cardiogenic shock. Am Heart J 125:919–929, 1993.

    Article  PubMed  CAS  Google Scholar 

  8. Berger PB, Holmes DR, Jr., Stebbins AL, Bates ER, Califf RM, Topol EJ. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. Circulation 96:122–127, 1997.

    PubMed  CAS  Google Scholar 

  9. Boden WE, O’Rourke RA, Crawford MH, et al., and Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 338:1785–1792, 1998.

    Article  PubMed  CAS  Google Scholar 

  10. Bolooki H. Emergency cardiac procedures in patients in cardiogenic shock due to complications of coronary artery disease. Circulation 79:I137–I148, 1989.

    PubMed  CAS  Google Scholar 

  11. Bowers TR, O’Neill WW, Grines C, Pica MC, Safian RD, Goldstein JA. Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 338:933–940, 1998.

    Article  PubMed  CAS  Google Scholar 

  12. Braunwald E. Unstable angina. A classification. Circulation 80:410–414, 1989.

    PubMed  CAS  Google Scholar 

  13. Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med 313:1369–1375, 1985.

    Article  PubMed  CAS  Google Scholar 

  14. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onsetto-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283:2941–2947, 2000.

    Article  PubMed  CAS  Google Scholar 

  15. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344:1879–1887, 2001.

    Article  PubMed  CAS  Google Scholar 

  16. Canto JG, Every NR, Magid DJ, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med 342:1573–1580, 2000.

    Article  PubMed  CAS  Google Scholar 

  17. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329–1339, 1996.

    Article  Google Scholar 

  18. CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 349:1429–1435, 1997.

    Article  Google Scholar 

  19. Chew DP Moliterno DJ. A critical appraisal of platelet glycoprotein IIb/IIIa inhibition. J Am Coll Cardiol 36:2028–2035. 2000.

    Article  PubMed  CAS  Google Scholar 

  20. Croft CH, Nicod P, Corbett JR, et al. Detection of acute right ventricular infarction by right precordial electrocardiography. Am J Cardiol 50:421–427, 1982.

    Article  PubMed  CAS  Google Scholar 

  21. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357:1385–1390, 2001.

    Article  PubMed  CAS  Google Scholar 

  22. Dell’Italia LJ, Starling MR, Blumhardt R, Lasher JC, O’Rourke RA. Comparative effects of volume loading, dobutamine, and nitroprusside in patients with predominant right ventricular infarction. Circulation 72:1327–1335, 1985.

    PubMed  CAS  Google Scholar 

  23. Edner M, Bonarjee VV, Nilsen DW, Berning J, Carstensen S, Caidahl K. Effect of enalapril initiated early after acute myocardial infarction on heart failure parameters, with reference to clinical class and echocardiographic determinants. CONSENSUS II Multi-Echo Study Group. Clin Cardiol 19:543–548, 1996.

    Article  PubMed  CAS  Google Scholar 

  24. Ellis SG, da Silva ER, Heyndrickx G, et al., and Investigators. R. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 90:2280–2284, 1994.

    PubMed  CAS  Google Scholar 

  25. Ferguson JJ, Califf RM, Antman EM, et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 292:45–54, 2004.

    Article  PubMed  CAS  Google Scholar 

  26. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2:57–66, 1986.

    Google Scholar 

  27. FRagmin and Fast Revascularisation During InStability in Coronary Artery Disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 354:708–715, 1999.

    Article  Google Scholar 

  28. Frick MH, Elo O, Haapa K, et al. Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. New Engl J Med 317:1237–1245, 1987.

    Article  PubMed  CAS  Google Scholar 

  29. Garber PJ, Mathieson AL, Ducas J, Patton JN, Geddes JS, Prewitt RM. Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration. Can J Cardiol 11:30–36, 1995.

    PubMed  CAS  Google Scholar 

  30. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 107:149–158, 2003.

    Article  PubMed  Google Scholar 

  31. Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. N Engl J Med 315:423–429, 1986.

    Article  PubMed  CAS  Google Scholar 

  32. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 337:1118–1123, 1997.

    Article  Google Scholar 

  33. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 340:1162–1168, 1999.

    Article  PubMed  CAS  Google Scholar 

  34. Grines C, Patel A, Zijlstra F, Weaver WD, Granger C, Simes RJ. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. Am Heart J 145:47–57, 2003.

    Article  PubMed  CAS  Google Scholar 

  35. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 328:673–679, 1993.

    Article  PubMed  CAS  Google Scholar 

  36. Gruppo Italiano per lo Studio della Sopravvinza nell’Infarto Miocardico (GISSI). GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343:1115–1122, 1994.

    PubMed  Google Scholar 

  37. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1:397–402, 1986.

    PubMed  Google Scholar 

  38. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329:1615–1622, 1993.

    Article  Google Scholar 

  39. GUSTO IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 335:775–782, 1996.

    Article  Google Scholar 

  40. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. New Engl J Med 329:673–682, 1993.

    Article  Google Scholar 

  41. Hochman JS, Boland J, Sleeper LA, et al. and Investigators SR. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. Circulation 91:873–881, 1995.

    PubMed  CAS  Google Scholar 

  42. Hochman JS, Sleeper LA, Webb JG, et al. and SHOCK (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock) Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341:625–634, 1999.

    Article  PubMed  CAS  Google Scholar 

  43. Hochman JS, Sleeper LA, White HD, et al. One-year survival following early revascularization for cardiogenic shock. JAMA 285:190–192. 2001.

    Article  PubMed  CAS  Google Scholar 

  44. Hollenberg SM Hoyt JW. Pulmonary artery catheters in cardiovascular disease. New Horizons 5:207–213, 1997.

    PubMed  CAS  Google Scholar 

  45. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med 131:47–59, 1999.

    PubMed  CAS  Google Scholar 

  46. Holmes DR, Jr., Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 26:668–674, 1995.

    Article  PubMed  Google Scholar 

  47. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2:349–360, 1988.

    Google Scholar 

  48. ISIS-4 (Fourth International Study of Infarct Survival) Study Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345:669–685, 1995.

    Article  Google Scholar 

  49. Jaffe AS, Ravkilde J, Roberts R, et al. It’s time for a change to a troponin standard. Circulation 102:1216–1220, 2000.

    PubMed  CAS  Google Scholar 

  50. Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83:902–912, 1991.

    PubMed  CAS  Google Scholar 

  51. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13–20, 2003.

    Article  PubMed  Google Scholar 

  52. Khan SS Gray RJ. Valvular emergencies. Cardiol Clin 9:689–709, 1991.

    PubMed  CAS  Google Scholar 

  53. Killen DA, Piehler JM, Borkon AM, Gorton ME, Reed WA. Early repair of postinfarction ventricular septal rupture. Ann Thorac Surg 63:138–142, 1997.

    Article  PubMed  CAS  Google Scholar 

  54. Kinch JW Ryan TJ. Right ventricular infarction. N Engl J Med 330:1211–1217, 1994.

    Article  PubMed  CAS  Google Scholar 

  55. Lauler DP. Magnesium—coming of age. Am J Cardiol 63:1g–3g, 1989.

    Article  PubMed  CAS  Google Scholar 

  56. Lee TH Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis. Ann Intern Med 105:221–233, 1986.

    PubMed  CAS  Google Scholar 

  57. Lewis HD, Jr., Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 309:396–403, 1983.

    Article  PubMed  Google Scholar 

  58. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104:365–372. 2001.

    PubMed  CAS  Google Scholar 

  59. Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251:365–374, 1984.

    Article  Google Scholar 

  60. Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339:1349–1357, 1998.

    Article  Google Scholar 

  61. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. Jama 260:1910–1916, 1988.

    Article  PubMed  CAS  Google Scholar 

  62. MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. Eur Heart J 6:199–226, 1985.

    Google Scholar 

  63. Ohman EM, Armstrong PW, Christenson RH, et al. and Investigators GI. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. New Engl J Med 335:133–1341, 1996.

    Article  Google Scholar 

  64. Oler A, Whooley MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. Jama 276:811–815, 1996.

    Article  PubMed  CAS  Google Scholar 

  65. PARAGON Investigators. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. Circulation 97:2386–2395, 1998.

    Google Scholar 

  66. Pfeffer MA, Braunwald E, Moye LA, et al. and Investigators. S. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 327:669–677, 1992.

    Article  PubMed  CAS  Google Scholar 

  67. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina. N Engl J Med 338:1498–1505, 1998.

    Article  Google Scholar 

  68. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 338:1488–1497, 1998.

    Article  Google Scholar 

  69. Rapaport E. Serum enzymes and isoenzymes in the diagnosis of acute myocardial infarction. Part II: Isoenzymes. Mod Concepts Cardiovasc Dis 46:47–50, 1977.

    PubMed  CAS  Google Scholar 

  70. Reardon MJ, Carr CL, Diamond A, et al. Ischemic left ventricular free wall rupture: prediction, diagnosis, and treatment. Ann Thorac Surg 64:1509–1513, 1997.

    Article  PubMed  CAS  Google Scholar 

  71. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 36:2056–2063, 2000.

    Article  PubMed  CAS  Google Scholar 

  72. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 34:890–911. 1999.

    Article  PubMed  CAS  Google Scholar 

  73. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New Engl J Med 335:1001–1009, 1996.

    Article  PubMed  CAS  Google Scholar 

  74. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36:1123–1129. 2000.

    Article  PubMed  CAS  Google Scholar 

  75. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383–1389, 1994.

    Article  Google Scholar 

  76. Simoons ML. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet 357:1915–1924, 2001.

    Article  PubMed  CAS  Google Scholar 

  77. Spodick DH. Diagnostic electrocardiographic sequences in acute pericarditis. Significance of PR segment and PR vector changes. Circulation 48:575–580, 1973.

    PubMed  CAS  Google Scholar 

  78. The International Collaborative Study Group. Reduction of infarct size with the early use of timolol in acute myocardial infarction. New Engl J Med 310:9–15, 1984.

    Article  Google Scholar 

  79. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 339:436–443, 1998.

    Article  Google Scholar 

  80. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 319:1105–1111, 1988.

    Article  PubMed  CAS  Google Scholar 

  81. TIMI Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction. Results of the TIMI IIIB Trial. Circulation 89:1545–1556, 1994.

    Google Scholar 

  82. TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 320:618–627, 1989.

    Article  Google Scholar 

  83. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 312:932–936, 1985.

    Google Scholar 

  84. Urban P, Stauffer JC, Bleed D, et al. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J 20:1030–1038, 1999.

    Article  PubMed  CAS  Google Scholar 

  85. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial—PRAGUE-2. Eur Heart J 24:94–104, 2003.

    Article  PubMed  CAS  Google Scholar 

  86. Willerson JT, Curry GC, Watson JT, et al. Intraaortic balloon counterpulsation in patients in cardiogenic shock, medically refractory left ventricular failure and/or recurrent ventricular tachycardia. Am J Med 58:183–191, 1975.

    Article  PubMed  CAS  Google Scholar 

  87. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494–502, 2001.

    Article  PubMed  CAS  Google Scholar 

  88. Zehender M, Kasper W, Kauder E, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. New Engl J Med 328:981–988, 1993.

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

(2006). Acute Coronary Syndromes. In: Cardiology in Family Practice. Current Clinical Practice. Humana Press. https://doi.org/10.1385/1-59745-042-1:1

Download citation

  • DOI: https://doi.org/10.1385/1-59745-042-1:1

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-509-5

  • Online ISBN: 978-1-59745-042-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation